GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,629.00
Bid: 1,629.00
Ask: 1,629.50
Change: -11.00 (-0.67%)
Spread: 0.50 (0.031%)
Open: 1,633.00
High: 1,641.00
Low: 1,611.00
Prev. Close: 1,640.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks lower as investors tread cautiously

Mon, 31st Mar 2014 16:58

- ECB under pressure to move on rates- Stocks erase gains but near three-week highs- Copper futures lower ahead of manufacturing PMIs- Small Russian troop pull backtechMARK 2,764.65 +0.09%FTSE 100 6,598.37 -0.26%FTSE 250 16,273.72 +0.57%UK stocks ended the day slightly lower as investors opted to bide their time ahead of Friday's US non-farm payrolls report and a barrage of data on the global manufacturing sector due out tomorrow.Worth noting, copper futures were changing hands at $303 per pound in early morning trading on COMEX, moving lower by approximately 0.51%. Acting as a backdrop, and linked to the above, a fair bit of market commentary could be seen referencing the risk of a steeper than expected slowdown in China's economy. Further weighing on sentiment was a weaker than expected reading on mortgage approvals for February. Data from the Bank of England revealed a decline to a monthly pace of 70,309, in comparison to the 76,753 seen in the month before and the 75,000 expected by the consensus. In parallel, European stocks were also getting weighed down by traders' cautiousness ahead of Thursday European Central Bank policy meeting. Reza Moghadam, Director of the IMF's European Department said today the central bank still has room to cut interest rates in face of the considerable downwards pressure on inflation.Figures released on Monday showed the annual rate of Eurozone consumer price inflation easing to a five-year low of 0.5% in March, down from 0.8% in February and below the 0.6% consensus forecast. The 'core' rate, which excludes volatile factors such as energy, food, alcohol and tobacco, fell to 0.8% from 1%, as expected.Ben May, European Economist at Capital Economics said that the slowdown in annual price rises was probably due to the timing of Easter, which fell in March last year. "But while we expect both headline and core inflation to pick up in April, underlying inflationary pressures will remain weak thanks to the large amount of spare economic capacity and the euro's strength," he said.May said it is "only a matter of time" before the European Central Bank (ECB) will decide that it needs to take "further policy action to prevent a worsening of the medium-term inflation outlook".Speaking in afternoon, Ukrainian Defence Ministry official Major-General Oleksandr Rozmaznin said the number of Russian troops deployed on the border with Ukraine is decreasing. He was unable to confirm numbers. "The number has definitely dropped and it (the situation) has calmed down. We won't rejoice and shout 'Hurray'. It doesn't matter how many of them there are, we just need to make sure our defences are strong," he said, according to Reuters.Babcock gains on nuclear contractEngineering group Babcock led gains after its joint venture, Cavendish Fluor Partnership, was selected as the preferred bidder for a UK government contract to manage the decommissioning of nuclear sites. According to the Nuclear Decommissioning Authority the 14-year contract is worth up to £7bn.Some miners also did well, including Anglo American and Rio Tinto, after Credit Suisse named them as its top picks in the metals and mining sector. Anglo was applauded for its restructuring potential, while the bank said that Rio's shareholder returns could be "larger and [...] sooner than any of its peer group".Analysts at Barclays raised their target price on ARM Holdings from 1125p to 1200p while reiterating their overweight recommendation.Insurance stocks such as Resolution and Aviva edged higher as share prices attempted to recover from the sell-off that ensued on Friday on the news of a regulatory investigation into the industry. The Financial Conduct Authority is set to outline its report today.Power systems giant Rolls-Royce gained after winning a $50m one-year contract to support the US Marines Corps fleet of KC-130J air-to-air refuelling tankers. GlaxoSmithKline declined after saying the third phase of its study of darpladib failed to meet its target for the prevention of stroke.Peel Hunt upgraded stock in African Barrick Gold to 'buy' from 'hold'.FTSE 100 - RisersBabcock International Group (BAB) 1,347.00p +4.26%Pearson (PSON) 1,063.00p +2.31%Mondi (MNDI) 1,049.00p +2.24%ARM Holdings (ARM) 998.00p +2.10%WPP (WPP) 1,237.00p +1.81%Rio Tinto (RIO) 3,337.50p +1.77%BAE Systems (BA.) 414.20p +1.67%Petrofac Ltd. (PFC) 1,438.00p +1.55%G4S (GFS) 241.50p +1.51%Aviva (AV.) 477.00p +1.45%FTSE 100 - FallersSSE (SSE) 1,469.00p -2.78%Shire Plc (SHP) 2,945.00p -2.52%St James's Place (STJ) 825.00p -2.25%Associated British Foods (ABF) 2,781.00p -1.73%GlaxoSmithKline (GSK) 1,591.50p -1.64%Sports Direct International (SPD) 852.00p -1.62%AstraZeneca (AZN) 3,876.50p -1.55%Tullow Oil (TLW) 748.50p -1.51%Next (NXT) 6,600.00p -1.49%Whitbread (WTB) 4,162.00p -1.44%FTSE 250 - RisersEvraz (EVR) 79.70p +10.62%African Barrick Gold (ABG) 263.50p +6.51%Xaar (XAR) 938.00p +5.99%CSR (CSR) 725.50p +4.54%Imagination Technologies Group (IMG) 203.20p +4.26%AL Noor Hospitals Group (ANH) 1,074.00p +3.67%Informa (INF) 528.50p +3.53%Alent (ALNT) 317.00p +3.49%Debenhams (DEB) 79.95p +3.09%Daejan Holdings (DJAN) 4,890.00p +3.06%FTSE 250 - FallersFisher (James) & Sons (FSJ) 1,463.00p -2.27%esure Group (ESUR) 279.70p -2.24%Entertainment One Limited (ETO) 330.00p -2.22%NMC Health (NMC) 504.50p -2.04%Howden Joinery Group (HWDN) 372.10p -1.85%Carphone Warehouse Group (CPW) 324.90p -1.84%Cairn Energy (CNE) 166.90p -1.71%EnQuest (ENQ) 124.00p -1.67%Direct Line Insurance Group (DLG) 237.50p -1.66%Soco International (SIA) 396.00p -1.49%AB
More News
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.